Insider · CIK 0001968736
Diane E. Sullivan
Files at AMRN (AMARIN CORP PLC\UK), LXRX (LEXICON PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Diane E. Sullivan files SEC Form 4 as director at AMRN (AMARIN CORP PLC\UK), and also at LXRX (LEXICON PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Diane E. Sullivan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 14 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +89,312 | $0.00 | $0 | 126,122 | Jun 4, 2026 |
| Jun 3, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -89,312 | $0.00 | $0 | 0 | Jun 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +35,714 | $0.00 | $0 | 35,714 | May 4, 2026 |
| May 1, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +43,478 | $0.00 | $0 | 43,478 | May 4, 2026 |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | MOption exercise American Depositary Shares | +838 | - | - | 1,239 | Apr 21, 2026 |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | FTax withholding American Depositary Shares | -403 | $14.98 | $6,037 | 836 | Apr 21, 2026 |
| Apr 18, 2026 | AMRN AMARIN CORP PLC\UK | MOption exercise Restricted Stock Unitderivative | +838 | $0.00 | $0 | 838 | Apr 21, 2026 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +103,806 | $0.00 | $0 | 103,806 | Jun 3, 2025 |
| Jun 3, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitsderivative | +89,312 | $0.00 | $0 | 89,312 | Jun 3, 2025 |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Common Stock | +36,810 | $0.00 | $0 | 36,810 | May 13, 2025 |
| May 13, 2025 | LXRX LEXICON PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -36,810 | $0.00 | $0 | 0 | May 13, 2025 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | MOption exercise American Depositary Shares | +838 | - | - | 838 | Apr 22, 2025 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | FTax withholding American Depositary Shares | -437 | $9.11 | $3,981 | 401 | Apr 22, 2025 |
| Apr 18, 2025 | AMRN AMARIN CORP PLC\UK | MOption exercise Restricted Stock Unitderivative | +838 | $0.00 | $0 | 1,676 | Apr 22, 2025 |
Questions about Diane E. Sullivan
Answered from the filings on this page, as of the latest one.
Is Diane E. Sullivan buying or selling?
Diane E. Sullivan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Diane E. Sullivan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Diane E. Sullivan has 0.
Where does Diane E. Sullivan file Form 4?
Diane E. Sullivan has filed Form 4 at AMRN (AMARIN CORP PLC\UK); LXRX (LEXICON PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.